Effect of R-(+)-alpha-lipoic Acid on Experimental Diabetic Retinopathy

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2006 Mar 8

PMID 16520919

Citations 39

Authors

J Lin

A Bierhaus

P Bugert

N Dietrich

Y Feng

F vom Hagen

P Nawroth

M Brownlee

H-P Hammes

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: Hyperglycaemia-induced mitochondrial overproduction of reactive oxygen species (ROS) is central to the pathogenesis of endothelial damage in diabetes. R-(+)-alpha-lipoic acid has advantages over classic antioxidants, as it distributes to the mitochondria, is regenerated by glycolytic flux, and has a low redox potential.

Methods: To assess the effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy, three groups of male Wistar rats were studied: non-diabetic controls, untreated diabetic controls, and diabetic rats treated with 60 mg/kg bodyweight R-(+)-alpha-lipoic acid i.p. for 30 weeks. Quantitative retinal morphometry included acellular occluded capillaries and pericyte numbers. The effects of R-(+)-alpha-lipoic acid on parameters of oxidative and nitrative stress, AGE and its receptor and nuclear factor kappa B (NFkappaB) were assessed by immunoblotting, and NFkappaB activation by electrophoretic mobility shift assay. Angiopoietin-2 and vascular endothelial growth factors were also determined by immunoblotting.

Results: After 30 weeks of diabetes, the number of acellular capillaries was significantly elevated in diabetic rats (57.1+/-10.6 acellular capillary segments [ac]/mm(2) of retinal area) compared with non-diabetic (19.8+/-5.1 ac/mm(2); p<0.001). Treatment with 60 mg/kg R-(+)-alpha-lipoic acid reduced the numbers by 88% (p<0.001 vs diabetic). Pericyte loss was also significantly inhibited in diabetic rats treated with R-(+)-alpha-lipoic acid (non-diabetic: 1,940+/-137 pericytes/mm(2)capillary area; untreated diabetic: 1,294+/-94 pericytes/mm(2)capillary area vs treated diabetic: 1,656+/-134 pericytes/mm(2); p<0.01). R-(+)-alpha-lipoic acid treatment reduced oxidative stress, normalised NFkappaB activation and angiopoietin-2 expression, and reduced vascular endothelial growth factor in the diabetic retina by 43% (p<0.0001).

Conclusions/interpretation: R-(+)-alpha-lipoic acid prevents microvascular damage through normalised pathways downstream of mitochondrial overproduction of ROS, and preserves pericyte coverage of retinal capillaries, which may provide additional endothelial protection.

Citing Articles

Dysregulation of amino acids balance as potential serum-metabolite biomarkers for diagnosis and prognosis of diabetic retinopathy: a metabolomics study.

Amiri-Dashatan N, Etemadi S, Besharati S, Farahani M, Moghaddam A J Diabetes Metab Disord. 2024; 23(2):2031-2042.

PMID: 39610496 PMC: 11599686. DOI: 10.1007/s40200-024-01462-y.

A Mediterranean Diet May Be Protective in the Development of Diabetic Retinopathy.

Bryl A, Mrugacz M, Falkowski M, Zorena K Int J Mol Sci. 2023; 24(13).

PMID: 37446322 PMC: 10342183. DOI: 10.3390/ijms241311145.

miRNA-124 Prevents Rat Diabetic Retinopathy by Inhibiting the Microglial Inflammatory Response.

Chen Y, Schlotterer A, Kurowski L, Li L, Dannehl M, Hammes H Int J Mol Sci. 2023; 24(3).

PMID: 36768614 PMC: 9917205. DOI: 10.3390/ijms24032291.

Research Progress on Mitochondrial Dysfunction in Diabetic Retinopathy.

Wu Y, Zou H Antioxidants (Basel). 2022; 11(11).

PMID: 36421435 PMC: 9686704. DOI: 10.3390/antiox11112250.

MicroRNA-124 Alleviates Retinal Vasoregression via Regulating Microglial Polarization.

Chen Y, Lin J, Schlotterer A, Kurowski L, Hoffmann S, Hammad S Int J Mol Sci. 2021; 22(20).

PMID: 34681723 PMC: 8538759. DOI: 10.3390/ijms222011068.

References

. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000; 355(9200):253-9. View

Aiello L, Avery R, Arrigg P, Keyt B, Jampel H, Shah S . Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994; 331(22):1480-7. DOI: 10.1056/NEJM199412013312203. View

Kowluru R, Odenbach S . Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes. 2004; 53(12):3233-8. DOI: 10.2337/diabetes.53.12.3233. View

Mayer-Davis E, Bell R, Reboussin B, Rushing J, Marshall J, Hamman R . Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. Ophthalmology. 1998; 105(12):2264-70. DOI: 10.1016/S0161-6420(98)91227-1. View

Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert P, Chen J . Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes. 2001; 50(12):2792-808. DOI: 10.2337/diabetes.50.12.2792. View

Quehenberger P, Bierhaus A, Fasching P, Muellner C, Klevesath M, Hong M . Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes. 2000; 49(9):1561-70. DOI: 10.2337/diabetes.49.9.1561. View

Hammes H, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C . Pericytes and the pathogenesis of diabetic retinopathy. Diabetes. 2002; 51(10):3107-12. DOI: 10.2337/diabetes.51.10.3107. View

Obrosova I, Minchenko A, MARINESCU V, Fathallah L, Kennedy A, Stockert C . Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia. 2001; 44(9):1102-10. DOI: 10.1007/s001250100631. View

Hammes H, Lin J, Bretzel R, Brownlee M, Breier G . Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes. 1998; 47(3):401-6. DOI: 10.2337/diabetes.47.3.401. View

10.

. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

11.

Liu J, Head E, Gharib A, Yuan W, Ingersoll R, Hagen T . Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid. Proc Natl Acad Sci U S A. 2002; 99(4):2356-61. PMC: 122369. DOI: 10.1073/pnas.261709299. View

12.

Brownlee M . Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414(6865):813-20. DOI: 10.1038/414813a. View

13.

Bustamante J, Lodge J, Marcocci L, Tritschler H, Packer L, Rihn B . Alpha-lipoic acid in liver metabolism and disease. Free Radic Biol Med. 1998; 24(6):1023-39. DOI: 10.1016/s0891-5849(97)00371-7. View

14.

Hammes H, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q . Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med. 2003; 9(3):294-9. DOI: 10.1038/nm834. View

15.

Hammes H, Bartmann A, Engel L, Wulfroth P . Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Diabetologia. 1997; 40(6):629-34. DOI: 10.1007/s001250050726. View

16.

Kowluru R, Kern T, ENGERMAN R, Armstrong D . Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes. 1996; 45(9):1233-7. DOI: 10.2337/diab.45.9.1233. View

17.

Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley P . Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes. 2003; 52(8):2110-20. DOI: 10.2337/diabetes.52.8.2110. View

18.

Ellis E, Guberski D, Grant M . Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med. 2000; 28(1):91-101. DOI: 10.1016/s0891-5849(99)00216-6. View

19.

Gilbert R, Vranes D, Berka J, Kelly D, Cox A, Wu L . Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest. 1998; 78(8):1017-27. View

20.

Hammes H, Alt A, Niwa T, Clausen J, Bretzel R, Brownlee M . Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia. 1999; 42(6):728-36. DOI: 10.1007/s001250051221. View